Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Clinical trial NCT07535138 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07535138
Sponsor: Air Force Military Medical University, China
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Membranous Nephropathy Lupus Nephritis (LN)IgA Nephropathy (IgAN)

Start date: 2026-05-01
Primary completion: 2028-06-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.